![Nitin Jain: CML response definitions](https://oncodaily.com/pub/uploads/2023/12/Nitin-Jain-e1720556284977.jpg)
Nitin Jain: CML response definitions
Fadi Haddad, Assistant Professor at the Leukemia Department at the MD Anderson Cancer Center, reposted a post by Nitin Jain, on X, adding:
”Very nice summary by Nitin Jain on the response definitions in CML according to the BCR::ABL1 levels and log reduction in leukemia.”
Quoting Nitin Jain’s post:
”Summary slide. CML response definitions.”
Source: Fadi Haddad/X and Nitin Jain/X
Nitin Jain is a Professor of Medicine at The University of Texas MD Anderson Cancer Center, Houston, USA. He leads the CAR T program for the Leukemia Department, MDACC, and received the Leukemia and Lymphoma Society (LLS) Scholar in Clinical Research and Translational Research Program awards in 2022. Specializing in acute and chronic leukemias, notably CLL and ALL, his research focuses on new drug development, reflected in his leadership of multiple investigator-initiated clinical trials.
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023